Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-beta1, metalloproteinase-1, and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C. [electronic resource]
Producer: 20060302Description: 6833-8 p. digitalISSN:- 1007-9327
- Adult
- Antiviral Agents -- therapeutic use
- Drug Carriers -- therapeutic use
- Female
- Hepatitis C, Chronic -- blood
- Humans
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Male
- Matrix Metalloproteinase 1 -- blood
- Middle Aged
- Polyethylene Glycols
- Recombinant Proteins
- Ribavirin -- therapeutic use
- Statistics as Topic
- Tissue Inhibitor of Metalloproteinase-1 -- blood
- Transforming Growth Factor beta -- blood
- Transforming Growth Factor beta1
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.